Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Oh

Showing results (341-350 of 1,297) with videos related to

Pageof 130
Sort By:
Muscle & Nerve|July 29, 2010
Focal conduction block in a case of tarsal tunnel syndromeDiogo F Almeida, Luciano Scremin, Sérgio F Zúniga, et al.
Plos Pathogens|May 26, 2026
Partial or complete blocking of gD binding to HVEM affects primary and latent HSV-1 infection as well as eye disease in HSV-1 infected miceDeepak Arya, Ujjaldeep Jaggi, Jay J Oh, et al.
Journal of Applied Microbiology|March 22, 2008
Biosynthesis of spectinomycin: heterologous production of spectinomycin and spectinamine in an aminoglycoside-deficient host, Streptomyces venezuelae YJ003L P Thapa, T-J Oh, K Liou, et al.
Ophthalmic Plastic and Reconstructive Surgery|July 28, 2025
Natural Killer T-Cell Lymphoma of the Face and OrbitAngela J Oh, Sara Emami, Jennifer J Chia, et al.
Annals of Neurology|April 1, 1979
Tarsal tunnel syndrome: electrophysiological studyS J Oh, P K Sarala, T Kuba, et al.
Biotechniques|July 26, 2011
Thickness profiling of formaldehyde-fixed cells by transmission-through-dye microscopyMariana Pelts, Sahil M Pandya, Christine J Oh, et al.
Mayo Clinic Proceedings|July 1, 1980
Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed diseaseJ Ludwig, T R Viggiano, D B McGill, et al.
Viruses|August 28, 2025
In the Absence of Type-1 IFN, HSV-1 LAT Increases γ34.5 Expression and Enhances Mortality in Infected MiceJay J Oh, Ujjaldeep Jaggi, Deepak Arya, et al.
Statistics in Medicine|December 2, 2017
Considerations for analysis of time-to-event outcomes measured with error: Bias and correction with SIMEXEric J Oh, Bryan E Shepherd, Thomas Lumley, et al.
The Urologic Clinics of North America|February 23, 1999
Evaluation and management of the man who has failed primary curative therapy for prostate cancerD K Ornstein, J Oh, J D Herschman, et al.
Pageof 130

Showing results (341-350 of 1,297) with videos related to

Sort By:
Pageof 130
Muscle & Nerve|July 29, 2010
Focal conduction block in a case of tarsal tunnel syndromeDiogo F Almeida, Luciano Scremin, Sérgio F Zúniga, et al.
Plos Pathogens|May 26, 2026
Partial or complete blocking of gD binding to HVEM affects primary and latent HSV-1 infection as well as eye disease in HSV-1 infected miceDeepak Arya, Ujjaldeep Jaggi, Jay J Oh, et al.
Journal of Applied Microbiology|March 22, 2008
Biosynthesis of spectinomycin: heterologous production of spectinomycin and spectinamine in an aminoglycoside-deficient host, Streptomyces venezuelae YJ003L P Thapa, T-J Oh, K Liou, et al.
Ophthalmic Plastic and Reconstructive Surgery|July 28, 2025
Natural Killer T-Cell Lymphoma of the Face and OrbitAngela J Oh, Sara Emami, Jennifer J Chia, et al.
Annals of Neurology|April 1, 1979
Tarsal tunnel syndrome: electrophysiological studyS J Oh, P K Sarala, T Kuba, et al.
Biotechniques|July 26, 2011
Thickness profiling of formaldehyde-fixed cells by transmission-through-dye microscopyMariana Pelts, Sahil M Pandya, Christine J Oh, et al.
Mayo Clinic Proceedings|July 1, 1980
Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed diseaseJ Ludwig, T R Viggiano, D B McGill, et al.
Viruses|August 28, 2025
In the Absence of Type-1 IFN, HSV-1 LAT Increases γ34.5 Expression and Enhances Mortality in Infected MiceJay J Oh, Ujjaldeep Jaggi, Deepak Arya, et al.
Statistics in Medicine|December 2, 2017
Considerations for analysis of time-to-event outcomes measured with error: Bias and correction with SIMEXEric J Oh, Bryan E Shepherd, Thomas Lumley, et al.
The Urologic Clinics of North America|February 23, 1999
Evaluation and management of the man who has failed primary curative therapy for prostate cancerD K Ornstein, J Oh, J D Herschman, et al.
Pageof 130